Literature DB >> 12213801

Glutamate racemase is an endogenous DNA gyrase inhibitor.

Makoto Ashiuchi1, Eriko Kuwana, Takashi Yamamoto, Kazuya Komatsu, Kenji Soda, Haruo Misono.   

Abstract

Almost all bacteria possess glutamate racemase to synthesize d-glutamate as an essential component of peptidoglycans in the cell walls. The enforced production of glutamate racemase, however, resulted in suppression of cell proliferation. In the Escherichia coli JM109/pGR3 clone, the overproducer of glutamate racemase, the copy number (i.e. replication efficiency) of plasmid DNA declined dramatically, whereas the E. coli WM335 mutant that is defective in the gene of glutamate racemase showed little genetic competency. The comparatively low and high activities for DNA supercoiling were contained in the E. coli JM109/pGR3 and WM335 cells, respectively. Furthermore, we found that the DNA gyrase of E. coli was modulated by the glutamate racemase of E. coli in the presence of UDP-N-acetylmuramyl-l-alanine, which is a peptidoglycan precursor and functions as an absolute activator for the racemase. This is the first finding of the enzyme protein participating in both d-amino acid metabolism and DNA processing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213801     DOI: 10.1074/jbc.C200253200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Moonlighting role of a poly-gamma-glutamate synthetase component from Bacillus subtilis: insight into novel extrachromosomal DNA maintenance.

Authors:  Daisuke Yamashiro; Yutaka Minouchi; Makoto Ashiuchi
Journal:  Appl Environ Microbiol       Date:  2011-02-25       Impact factor: 4.792

2.  Metabolic engineering for L-glutamine overproduction by using DNA gyrase mutations in Escherichia coli.

Authors:  Mikiro Hayashi; Kazuhiko Tabata
Journal:  Appl Environ Microbiol       Date:  2013-03-01       Impact factor: 4.792

Review 3.  Dynamic dissociating homo-oligomers and the control of protein function.

Authors:  Trevor Selwood; Eileen K Jaffe
Journal:  Arch Biochem Biophys       Date:  2011-12-13       Impact factor: 4.013

4.  Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor design.

Authors:  Melissa May; Shahila Mehboob; Debbie C Mulhearn; Zhiqiang Wang; Huidong Yu; Gregory R J Thatcher; Bernard D Santarsiero; Michael E Johnson; Andrew D Mesecar
Journal:  J Mol Biol       Date:  2007-06-04       Impact factor: 5.469

5.  Investigation of the essentiality of glutamate racemase in Mycobacterium smegmatis.

Authors:  Yang Li; Roman Mortuza; Daniel L Milligan; Sieu L Tran; Ulrich Strych; Gregory M Cook; Kurt L Krause
Journal:  J Bacteriol       Date:  2014-09-22       Impact factor: 3.490

Review 6.  Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.

Authors:  Frédéric Collin; Shantanu Karkare; Anthony Maxwell
Journal:  Appl Microbiol Biotechnol       Date:  2011-09-09       Impact factor: 4.813

7.  Glutamate racemase from Mycobacterium tuberculosis inhibits DNA gyrase by affecting its DNA-binding.

Authors:  Sugopa Sengupta; Meera Shah; Valakunja Nagaraja
Journal:  Nucleic Acids Res       Date:  2006-10-04       Impact factor: 16.971

Review 8.  Glutamate racemase as a target for drug discovery.

Authors:  Stewart L Fisher
Journal:  Microb Biotechnol       Date:  2008-05-11       Impact factor: 5.813

9.  YacG from Escherichia coli is a specific endogenous inhibitor of DNA gyrase.

Authors:  Sugopa Sengupta; Valakunja Nagaraja
Journal:  Nucleic Acids Res       Date:  2008-06-27       Impact factor: 16.971

10.  Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions.

Authors:  Mina Hemmati; Elham Zohoori; Omid Mehrpour; Mehdi Karamian; Somaye Asghari; Asghar Zarban; Roya Nasouti
Journal:  EXCLI J       Date:  2015-08-04       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.